Formulary Monographs [MERCAPTOPURINE, 1000]

MERCAPTOPURINE
ANTINEOPLASTICS
Acute Lymphocytic Leukemia
Nausea, vomiting and anorexia, leukopenia, thrombocytopenia. An antimetabolite. C.f. prescribing in renal disease p. 32.
2.5mg/kg/day or 50-70mg/m2 daily adjusted according to response and tolerance. Maintainence: 1.5-2.5mg/kg/day .
Mercaptopurine should only be used during pregnancy when there are no alternatives and benefit outweighs risk.
Mercaptopurine is distributed in breastmilk. Breastfeeding is not recommended during therapy.